English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[5228]
News
[12046]
Articles
[155]
Editorials
[5]
Conferences
[240]
e
learning
[12]
ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma
ASCO 2012: New quality measures tested to encourage better taking of family histories and referral to genetic...
ASCO 2012: Duloxetine, a serotonin-norepinephrine reuptake inhibitor anti-depressant, is first effective treatment...
ASCO 2012: Afatinib delays progression of advanced lung adenocarcinomas, particularly in genetic subset of tumours
ASCO 2012: Study shows routine molecular testing of non-small cell lung cancers is feasible in community settings
ASCO 2012: Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies
ASCO 2012: Newer, more costly drugs no better than standard weekly paclitaxel as first line therapy for locally...
ASCO 2012: New BRAF inhibitor dabrafenib delays disease progression better than standard chemotherapy in patients...
ASCO 2012: Lower levels of radiation therapy than previously thought can increase risk of breast cancer among...
ASCO 2012: Study finds intermittent hormonal therapy less effective than continuous therapy in certain men with...
<
1
...
1170
1171
1172
1173
1174
...
1205
>
More from
e
cancer